Vertex Pharmaceuticals Stock News

Related Stocks: MRK , AZN , IDXX , GILD , CRL , PHG , MRNA , GH , QGEN , ALKS , BHVN , STVN , MTD , VRTX , QURE , ALXN , A , STE ,

Related Stocks: IDXX , SRPT , MOH , ZTS , AZN , LH , MRNA , GH , ICLR , JAZZ , RLYB , FUSN , VRTX , AMED , ALXN , CNC , INCY , IOVA ,

Gateway Investment Advisers LLC lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 0.9% in the third quarter, Holdings Channel reports. The institutional investor owned 102,369 shares of the pharmaceutical companys stock after selling 884 shares during the period. Gateway Investment Advisers LLCs holdings in Vertex Pharmaceuticals were worth $18,569,000 as of its []

Kestra Advisory Services LLC lessened its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 10.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,479 shares of the pharmaceutical companys stock after selling 2,320 shares during the period. Kestra Advisory Services LLCs holdings in Vertex Pharmaceuticals []

NEXT Financial Group Inc cut its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 85.2% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 428 shares of the pharmaceutical companys stock after selling 2,465 shares during the period. NEXT Financial []

Sound View Wealth Advisors Group LLC boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 18.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,856 shares of the pharmaceutical companys stock after buying an additional 454 shares during the []

Recent Pipeline Updates Show Vertex Is Not Just About Cystic Fibrosis

Everence Capital Management Inc. lifted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 27.5% in the third quarter, Holdings Channel reports. The firm owned 7,274 shares of the pharmaceutical companys stock after purchasing an additional 1,570 shares during the period. Everence Capital Management Inc.s holdings in Vertex Pharmaceuticals were worth $1,319,000 at the []

They are among the 12 drug companies with the most resources for acquisitions Related Stocks: MRK , JAZZ , AZN , PFE , JNJ , MRNA , BNTX , REGN , VRTX , NVS , NVO , GSK , FOLD , PTLA , AIMT , GTHX ,

Vertex Pharmaceuticals (NASDAQ:VRTX) had its price objective hoisted by Royal Bank of Canada from $250.00 to $265.00 in a report released on Thursday morning, The Fly reports. Royal Bank of Canada currently has an outperform rating on the pharmaceutical companys stock. Other analysts have also issued reports about the stock. Piper Sandler lowered shares of []

Buying innovators and disruptors at a discount is a smart way to set yourself up for long-term success.

Positive clinical trial read-outs bode well for this big-name biotech stock.

Positive clinical trial read-outs bode well for this big-name biotech stock.

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have received an average rating of Hold from the twenty-two research firms that are currently covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and thirteen have assigned a buy rating to the company. The average 1-year []

Two big biotechs and one smaller one that could be winners over the long term.